Christelle Hureau Selected Research

Ions

12/2021	Hybrid Bis-Histidine Phenanthroline-Based Ligands to Lessen Aβ-Bound Cu ROS Production: An Illustration of Cu(I) Significance.
6/2021	Measurement of Interpeptidic CuII Exchange Rate Constants of CuII-Amyloid-β Complexes to Small Peptide Motifs by Tryptophan Fluorescence Quenching.
12/2020	The aroylhydrazone INHHQ prevents memory impairment induced by Alzheimer's-linked amyloid-β oligomers in mice.
10/2019	Copper-Targeting Approaches in Alzheimer's Disease: How To Improve the Fallouts Obtained from in Vitro Studies.
6/2018	Kinetics Are Crucial When Targeting Copper Ions to Fight Alzheimer's Disease: An Illustration with Azamacrocyclic Ligands.
1/2018	Corrigendum: Kinetics Are Crucial When Targeting Copper Ions to Fight Alzheimer's Disease: An Illustration with Azamacrocyclic Ligands.
10/2017	Mutual interference of Cu and Zn ions in Alzheimer's disease: perspectives at the molecular level.
10/2016	How Zn can impede Cu detoxification by chelating agents in Alzheimer's disease: a proof-of-concept study.
11/2015	Copper(I/II), α/β-Synuclein and Amyloid-β: Menage à Trois?
12/2013	Identifying, by first-principles simulations, Cu[amyloid-β] species making Fenton-type reactions in Alzheimer's disease.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christelle Hureau Research Topics

Disease

52	Alzheimer Disease (Alzheimer's Disease) 02/2022 - 02/2009
9	Amyloid Plaque 01/2021 - 10/2012
5	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2019 - 11/2010
1	Neoplasms (Cancer) 01/2022
1	Nervous System Diseases (Neurological Disorders) 12/2021
1	Neuroinflammatory Diseases 01/2021
1	Prion Diseases (Transmissible Spongiform Encephalopathies) 12/2017
1	Parkinson Disease (Parkinson's Disease) 05/2015
1	Burns 09/2006

Drug/Important Bio-Agent (IBA)

36	Peptides (Polypeptides)IBA 12/2021 - 02/2009
35	Amyloid (Amyloid Fibrils)IBA 12/2021 - 10/2010
20	CopperIBA 01/2022 - 02/2009
20	IonsIBA 12/2021 - 02/2009
16	MetalsIBA 12/2021 - 02/2009
9	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2021 - 10/2009
6	ZincIBA 12/2021 - 02/2009
5	LigandsIBA 12/2021 - 12/2017
4	SynucleinsIBA 01/2021 - 05/2015
4	IronIBA 12/2017 - 09/2011
4	Amyloid beta-PeptidesIBA 10/2016 - 02/2009
3	Chelating AgentsIBA 02/2022 - 10/2016
2	Prion ProteinsIBA 01/2021 - 12/2017
2	Proteins (Proteins, Gene)FDA Link 12/2020 - 09/2006
2	AntioxidantsIBA 06/2018 - 08/2016
1	ThiosemicarbazonesIBA 01/2022
1	PeptoidsIBA 11/2021
1	Islet Amyloid PolypeptideIBA 01/2021
1	Protein Isoforms (Isoforms)IBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	Neuroprotective AgentsIBA 12/2020
1	Pharmaceutical PreparationsIBA 01/2019
1	Biological ProductsIBA 06/2018
1	ProdrugsIBA 04/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Amyloidogenic ProteinsIBA 12/2017
1	Coordination ComplexesIBA 12/2017
1	peptide IIBA 10/2016
1	Methionine (L-Methionine)FDA Link 01/2016
1	tau Proteins (tau Protein)IBA 10/2013
1	thioflavin TIBA 10/2013
1	Pyrrolidonecarboxylic Acid (Pyroglutamic Acid)IBA 12/2012
1	Heme (Haem)IBA 01/2012
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 10/2010
1	Oxygen (Dioxygen)IBA 10/2010

Therapy/Procedure

1	Chelation Therapy (Therapy, Chelation) 06/2018